| abstract |
Disclosed herein are active metabolites ("M20") of molecules useful as thrombin receptor antagonists. Also disclosed are formulations of this compound, synthetic routes for this compound, and methods of treating various cardiovascular conditions, including acute coronary syndromes and peripheral arterial disease, and methods of providing secondary prophylaxis by oral administration of active metabolites. |